BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...

Ottawa, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The global optic nerve atrophy treatment market size is calculated at USD 2.75 billion in 2025 and is expected to reach around USD 5.87 billion by 2034, ...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...

DelveInsight’s “Optic Atrophy Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Optic Atrophy, historical and forecasted epidemiology as well as ...

USA, February 24, 2023 /EINPresswire.com/ -- NAION or Non-arteritic Ischemic Optic Neuropathy is a type of stroke of the optic nerve that is not from inflammation. It ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

Please provide your email address to receive an email when new articles are posted on . Neuro-ophthalmologists have a lighthearted attitude about the perception of their specialty because, for many ...

(MENAFN- GlobeNewsWire - Nasdaq) The global optic nerve atrophy treatment market size was valued at USD 2.53 billion in 2024 and is predicted to hit around USD 5.87 billion by 2034, rising at a 8.85% ...